Literature DB >> 7515505

Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis.

U Utz1, J A Brooks, H F McFarland, R Martin, W E Biddison.   

Abstract

The pathogenesis of multiple sclerosis (MS) is thought to involve a T-cell-mediated autoimmune process. Experimental allergic encephalomyelitis (EAE), an animal model resembling MS, can be induced by immunization with myelin antigens such as myelin basic protein. The T-cell antigen receptor (TCR) usage in EAE is highly restricted in some strains of animals and experimental treatments targeting the TCR have been successful in EAE. Examination of the TCR beta-chain variable-region (V beta) usage of MBP-specific T-cell lines in MS patients has produced conflicting results. Our previous studies of TCR alpha-chain variable-region usage in monozygotic twins demonstrated a general skewing of the TCR repertoire in individuals with MS. This skewing became apparent only after stimulation with antigens; in peripheral blood lymphocyte preparations from individuals with MS V alpha 8-bearing T cells were preferentially selected by stimulation with myelin basic protein. In the present study we examined complementarity-determining region 3 of those V alpha 8-positive TCRs. Marked sequence heterogeneity was found in all individuals with severe MS. In contrast, restricted areas of complementarity-determining region 3 were found in healthy control individuals and in individuals with a mild form of MS. Sequences from tetanus toxoid-specific V alpha 8-positive T cells generated from the same individuals were relatively homogeneous within individuals regardless of disease activity and were distinct from the sequences of complementarity-determining region 3 in myelin basic protein-stimulated lines. These findings suggest that disease severity may be associated with increased heterogeneity of myelin antigen-specific T cells and could reflect an impaired ability of the immune system to down-regulate these anti-self responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515505      PMCID: PMC44037          DOI: 10.1073/pnas.91.12.5567

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.

Authors:  M D Howell; S T Winters; T Olee; H C Powell; D J Carlo; S W Brostoff
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.

Authors:  A A Vandenbark; G Hashim; H Offner
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

3.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Authors:  D C Wraith; D E Smilek; D J Mitchell; L Steinman; H O McDevitt
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  T cells responsive to myelin basic protein in patients with multiple sclerosis.

Authors:  M Allegretta; J A Nicklas; S Sriram; R J Albertini
Journal:  Science       Date:  1990-02-09       Impact factor: 47.728

5.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention.

Authors:  H Acha-Orbea; D J Mitchell; L Timmermann; D C Wraith; G S Tausch; M K Waldor; S S Zamvil; H O McDevitt; L Steinman
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

6.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.

Authors:  J L Urban; V Kumar; D H Kono; C Gomez; S J Horvath; J Clayton; D G Ando; E E Sercarz; L Hood
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

7.  Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients.

Authors:  J R Oksenberg; S Stuart; A B Begovich; R B Bell; H A Erlich; L Steinman; C C Bernard
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different.

Authors:  F R Burns; X B Li; N Shen; H Offner; Y K Chou; A A Vandenbark; E Heber-Katz
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  J Zhang; S Markovic-Plese; B Lacet; J Raus; H L Weiner; D A Hafler
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  6 in total

1.  Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.

Authors:  Ryuji Kubota; Samantha S Soldan; Roland Martin; Steven Jacobson
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

2.  A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients.

Authors:  A Uccelli; D Giunti; M Salvetti; G Ristori; D Fenoglio; G Mancardi
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 3.  Mechanisms of the pathogenic autoimmune response in lupus: prospects for specific immunotherapy.

Authors:  S K Datta; C Mohan; A Desai-Mehta
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 4.  T-cell antigen receptors in rheumatoid arthritis.

Authors:  L I Sakkas; P F Chen; C D Platsoucas
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

5.  Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.

Authors:  A Desai-Mehta; C Mao; S Rajagopalan; T Robinson; S K Datta
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

Review 6.  Experimental immunotherapies for multiple sclerosis.

Authors:  R Martin; H McFarland
Journal:  Springer Semin Immunopathol       Date:  1996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.